Tuberculosis


  • Structure for Promising Tuberculosis Drug Target is Discovered
    Researchers at Johns Hopkins have figured out the three-dimensional shape of the protein responsible for creating unique bonds within the cell wall of the bacteria that cause tuberculosis. The bonds make the bacteria resistant to currently available drug therapies, ...More
    October 26, 2012 Posted in News
  • Antibiotic Shows Promise in Treating Extensively Drug-Resistant Tuberculosis
    When tested in patients hospitalized with extensively drug-resistant tuberculosis (XDR-TB) unresponsive to previous treatment, linezolid, an antibiotic used to treat severe bacterial infections, proved largely effective when added to the patients' ongoing TB treatment ...More
    October 18, 2012 Posted in News
  • 20 Million Lives Saved Through TB Care and Control
    An estimated 20 million people are alive today as a direct result of tuberculosis (TB) care and control, according to the WHO Global tuberculosis report 2012. “In the space of 17 years, 51 million people have been successfully treated and cared for according to WHO ...More
    October 17, 2012 Posted in News
  • TB Researchers Call for Greater Focus on the Quest for New Vaccines
    Drawing on recent findings of a significant rise in cases of drug-resistant tuberculosis in the UK and globally, top TB researchers at a briefing today in London called for greater focus on the quest for new vaccines—a crucial long-term, cost-effective method for addressing ...More
    October 15, 2012 Posted in News
  • New Tool Improves, Speeds TB Diagnosis
    Technology developed by scientists at the Methodist Hospital Research Institute could halve the time it takes to diagnose tuberculosis infection, and also tell doctors in a day or two whether the bacteria are drug resistant -- a process that currently takes weeks. Initial ...More
    September 10, 2012 Posted in News
  • Pain Drug Can Kill Resistant Tuberculosis
    An off-patent anti-inflammatory drug that costs around 2 cents for a daily dose in developing countries has been found by researchers at Weill Cornell Medical College to kill both replicating and non-replicating drug resistant tuberculosis in the laboratory -- a feat few ...More
    September 10, 2012 Posted in News
  • High Doses of Vitamin D Help TB Patients Recover More Quickly
    For decades before antibiotics became generally available, sunshine was used to treat tuberculosis. Now, for the first time, scientists have shown how and why heliotherapy might, indeed, have made a difference. A study led by researchers at Queen Mary, University of London, ...More
    September 4, 2012 Posted in News
  • TB Outbreaks Could be 'Solved' by DNA Tracking
    Reconstructing the spread of killer diseases such as tuberculosis (TB) from person to person using DNA sequencing quickly identifies the origin and movement of pathogens. This approach is directly informing public health strategies to control infectious disease outbreaks, ...More
    September 4, 2012 Posted in News
  • Integration of Active Tuberculosis Case Finding in a Mobile HIV-Testing Clinic is Feasible
    A research article by Katharina Kranzer from the London School of Hygiene & Tropical Medicine and colleagues describe the feasibility and costs of an active tuberculosis case finding project in Cape Town, South Africa. The study describes the integration of tuberculosis ...More
    August 8, 2012 Posted in News
  • Researchers Call for Change in New FDA Recommendation on HIV and TB Drug Doses
    In January, 2012, the Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease. The ...More
    July 24, 2012 Posted in News